Publications by authors named "Isabelle Desombere"

Claim this Profile
S
Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients.
Nicolas Gemander, Julika Neumann, Rafael Veiga, Isabelle Etienne, Teresa Prezzemolo, Isabelle Desombere

NPJ Vaccines· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients.
Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S Kelkar, Shilpee Sharma, Isabelle Desombere

Vaccine· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.
Katie Steenackers, Nikita Hanning, Liesbeth Bruckers, Isabelle Desombere, Arnaud Marchant

Vaccine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistent defect in SARS-CoV-2 humoral and cellular immunity in lung transplant recipients.
Isabelle Etienne, Delphine Kemlin, Nicolas Gemander, Véronique Olislagers, Alexandra Waegemans, Isabelle Desombere

J Heart Lung Transplant· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022.
Johan Van der Heyden, Victoria Leclercq, Els Duysburgh, Laura Cornelissen, Isabelle Desombere

Arch Public Health· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hybrid Immunity Overcomes Defective Immune Response to COVID-19 Vaccination in Kidney Transplant Recipients.
Nicolas Gemander, Delphine Kemlin, Stéphanie Depickère, Natasha S Kelkar, Pieter Pannus, Isabelle Desombere

Kidney Int Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype.
Maaike Cockx, Filomeen Haerynck, Levi Hoste, Rik Schrijvers, Jutte Van der Werff Ten Bosch, Isabelle Desombere

Clin Chem Lab Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Delphine Kemlin, Nicolas Gemander, Stéphanie Depickère, Véronique Olislagers, Daphnée Georges, Isabelle Desombere

Am J Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a rapid SARS-CoV-2 antibody test in general practice.
Julie Domen, Jan Yvan Jos Verbakel, Niels Adriaenssens, Beatrice Scholtes, Bart Peeters, Isabelle Desombere

BMJ Open· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Milena Callies, Ines Kabouche, Isabelle Desombere, Joanna Merckx, Mathieu Roelants

BMC Public Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Daphnée Georges, Sarah Houben, Isabelle Desombere

Vaccine· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study.
Joanna Merckx, Milena Callies, Ines Kabouche, Isabelle Desombere, Els Duysburgh

Epidemiol Infect· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Angelina Konnova, Fien H R De Winter, Akshita Gupta, Lise Verbruggen, An Hotterbeekx, Isabelle Desombere

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.
Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Isabelle Desombere

PLOS Glob Public Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-up.
Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, Pauline Van Ngoc, Jan Yvan Jos Verbakel, Isabelle Desombere

BMJ Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing Homes.
Pieter Pannus, Kristof Y Neven, Stéphane De Craeye, Leo Heyndrickx, Sara Vande Kerckhove, Isabelle Desombere

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Lorenzo Canti, Kevin K Ariën, Isabelle Desombere, Stéphanie Humblet-Baron, Pieter Pannus

Cancer Cell· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a microfluidic multiplex immunoassay for the determination of levels and avidity of serum antibodies to tetanus, diphtheria and pertussis antigens.
Debby Thomas, Doreen Dillaerts, Maaike Cockx, Louanne Ampofo, Joseph She, Isabelle Desombere

J Immunol Methods· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
Frédéric Baron, Lorenzo Canti, Kevin K Ariën, Delphine Kemlin, Isabelle Desombere

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study.
Victoria Leclercq, Nayema Van den Houte, Lydia Gisle, Inge Roukaerts, Cyril Barbezange, Isabelle Desombere

Viruses· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variant.
Kevin K Ariën, Leo Heyndrickx, Johan Michiels, Katleen Vereecken, Kurt Van Lent, Isabelle Desombere

NPJ Vaccines· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Role for B Cells to Transmit Hepatitis C Virus Infection.
Isabelle Desombere, Freya Van Houtte, Ali Farhoudi, Lieven Verhoye, Caroline Buysschaert

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional Analysis of Human and Feline Coronavirus Cross-Reactive Antibodies Directed Against the SARS-CoV-2 Fusion Peptide.
Nathalie Vanderheijden, Annelies Stevaert, Jiexiong Xie, Xiaolei Ren, Cyril Barbezange, Isabelle Desombere

Front Immunol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and incidence of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium during 1 year of the COVID-19 epidemic: prospective cohort study protocol.
Niels Adriaenssens, Beatrice Scholtes, Robin Bruyndonckx, Jan Y Verbakel, An De Sutter, Isabelle Desombere

BMJ Open· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.
Maria E Goossens, Kristof Y Neven, Pieter Pannus, Cyril Barbezange, Isabelle Thomas, Isabelle Desombere

Arch Public Health· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis